ARCHIVES

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

In Brief: NCAB Vacancies Remained Unfilled; AHF’s 20thAnniversary To Be Celebrated In NY May 24

May 5, 1989

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014